| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | OCERA THERAPEUTICS INC | 703,730 | 2,224,000 | 0.57% | ||
| 2 | STEMLINE THERAPEUTICS INC | 451,400 | 3,986,000 | 1.02% | ||
| 3 | Sierra Oncology, Inc. | 250,000 | 5,130,000 | 1.32% | ||
| 4 | Cynapsus Therapeutics Inc | 367,427 | 5,940,000 | 1.52% | ||
| 5 | ARCA biopharma Inc | 1,541,331 | 7,645,000 | 1.96% | ||
| 6 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 8,155,000 | 2.09% | ||
| 7 | ALCOBRA LTD | 1,500,000 | 9,060,000 | 2.32% | ||
| 8 | AVALANCHE BIOTECHNOLOGIES IN | 1,382,735 | 11,394,000 | 2.92% | ||
| 9 | AKARI THERAPEUTICS PLC | 527,842 | 12,666,000 | 3.25% | ||
| 10 | Ascendis Pharma | 811,152 | 14,357,000 | 3.68% | ||
| 11 | LIPOCINE INC NEW | 1,269,921 | 15,024,000 | 3.85% | ||
| 12 | ZAFGEN INC COM | 541,480 | 17,300,000 | 4.44% | ||
| 13 | COHERUS BIOSCIENCES INC COM | 870,269 | 17,441,000 | 4.47% | ||
| 14 | REGENXBIO INC COM | 1,083,454 | 20,178,000 | 5.17% | ||
| 15 | HERON THERAPEUTICS INC COM | 1,095,734 | 26,736,000 | 6.85% | ||
| 16 | GW PHARMACEUTICALS PLC | 311,853 | 28,494,000 | 7.31% | ||
| 17 | DBV Technologies | 693,810 | 45,612,000 | 11.69% | ||
| 18 | Anacor Pharmaceuticals Inc | 1,178,474 | 138,718,000 | 35.56% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011918, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
